Processa Pharmaceuticals ... (PCSA)
0.50
-0.05 (-8.93%)
At close: Mar 03, 2025, 3:59 PM
0.49
-1.90%
After-hours: Mar 03, 2025, 06:15 PM EST
Processa Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Cash & Equivalents | 4.71M | 6.5M | 16.5M | 15.42M | 691.54K | 1.74M | 2.85M | 3.24K | 2.09K | 21.23K | 186.86K | 1.03M | 2.79M | n/a |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | -2.15M | -1.9M | -1.12M | 1.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 5.54K | 5.54K | 5.54K | 5.54K | 5.54K | -2.53M | 5.54K | 5.53K | n/a | n/a | n/a | n/a | n/a | n/a |
| Receivables | n/a | n/a | 70.27K | 231.75K | n/a | 21.58K | 62.71K | n/a | n/a | 1.31K | 19.2K | 30.45K | 9.5K | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 222.02K | 228.26K | 48.75K | n/a | n/a |
| Other Current Assets | 926.3K | 3.77M | 1.76M | 554.71K | 631.21K | 257.83K | 41.45K | n/a | 102.07K | 162.51K | 160.77K | 50.37K | n/a | n/a |
| Total Current Assets | 5.63M | 8.39M | 18.33M | 16.2M | 1.01M | 2.02M | 2.95M | 3.24K | 104.16K | 379.21K | 514.71K | 1.16M | 2.8M | n/a |
| Property-Plant & Equipment | 148.61K | 227.59K | 74.18K | 159.04K | 228K | 17.38K | 25.82K | 22.39K | 159.00 | 466.41K | 369.77K | 316.36K | 1.2K | 20K |
| Goodwill & Intangibles | n/a | n/a | 8.06M | 8.85M | 9.64M | 10.44M | n/a | n/a | n/a | 1.7M | 2.05M | 2.41M | 2.5M | n/a |
| Total Long-Term Assets | 154.15K | 233.12K | 8.14M | 9.01M | 9.88M | 10.46M | 31.36K | 27.93K | 159.00 | 2.16M | 2.42M | 2.73M | 2.5M | 20K |
| Total Assets | 5.79M | 8.62M | 26.46M | 25.21M | 10.88M | 13.21M | 2.98M | 3.24K | 104.32K | 2.54M | 2.94M | 3.88M | 5.31M | 20K |
| Account Payables | 311.62K | 327.55K | 218.91K | 320.69K | 75.61K | 292.1K | 50.69K | 166.16K | 159.25K | 153.93K | 77.03K | 73.17K | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 483.91K | 257.15K | 58.16K | 155.5K | 150.00 | n/a | n/a |
| Short-Term Debt | 83.65K | 157.79K | 142.16K | 204.77K | 880.5K | 230K | 2.45M | 1.61M | 1.37M | 466.47K | 631.19K | 527.22K | 300K | n/a |
| Other Current Liabilities | 335.31K | 513.22K | 609.96K | 695.48K | 235.46K | 123.6K | 100.56K | 575.69K | 557.28K | 161.39K | 413.4K | 115.11K | 30.52K | n/a |
| Total Current Liabilities | 730.58K | 998.56K | 971.02K | 1.22M | 1.19M | 645.7K | 2.6M | 2.35M | 2.08M | 840.05K | 1.12M | 715.65K | 330.62K | n/a |
| Long-Term Debt | 66.91K | 150.55K | 7.38K | 123.35K | 147.39K | n/a | n/a | n/a | n/a | 494.07K | 145.46K | 606.16K | 2.2M | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | 400K | n/a | n/a | 9.96K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 66.91K | 150.55K | 7.38K | 1.05M | 1.68M | 2.87M | 9.96K | n/a | n/a | 494.07K | 145.46K | 606.16K | 2.2M | n/a |
| Total Liabilities | 797.48K | 1.15M | 978.4K | 2.27M | 2.87M | 3.51M | 2.61M | 2.35M | 2.08M | 1.33M | 1.27M | 1.32M | 2.53M | n/a |
| Total Debt | 150.55K | 229.45K | 78.46K | 328.12K | 1.03M | 230K | 2.45M | 1.61M | 1.37M | 960.53K | 776.64K | 1.13M | 2.5M | n/a |
| Common Stock | 129.00 | 1.61K | 1.57K | 1.42K | 549.00 | 3.87K | 3.53K | 1.1K | 1.1K | 1.09K | 808.00 | 190.00 | 280.00 | n/a |
| Retained Earnings | -75.37M | -64.25M | -36.82M | -25.4M | -10.98M | -7.62M | -3.86M | -15.25M | -14.87M | -12.91M | -6.81M | -3.43M | -941.1K | n/a |
| Comprehensive Income | -0.00 | 0.00 | 0.00 | n/a | 0.00 | -1.8M | -3.25K | -19.15K | -18.99K | -185.75K | -77.12K | -19.36K | -178 | n/a |
| Shareholders Equity | 4.99M | 7.47M | 25.49M | 22.94M | 8.01M | 9.7M | 373.16K | -2.35M | -1.98M | 1.21M | 1.67M | 2.56M | 2.78M | 20K |
| Total Investments | n/a | n/a | -2.15M | -1.9M | -1.12M | 1.8M | n/a | 1.02M | n/a | n/a | n/a | n/a | n/a | n/a |